Skip to main content

PROTECT: Pazopanib falls short as adjuvant therapy for high-risk RCC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
PROTECT: Pazopanib falls short as adjuvant therapy for high-risk RCC

User login

Username

Password

Reset your password

Type	Lead	score